These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9747541)

  • 41. Synthesis and antimycobacterial activity of 2-substituted halogenobenzimidazoles.
    Kazimierczuk Z; Andrzejewska M; Kaustova J; Klimesova V
    Eur J Med Chem; 2005 Feb; 40(2):203-8. PubMed ID: 15694655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antimycobacterial eudesmanolides from Inula helenium and Rudbeckia subtomentosa.
    Cantrell CL; Abate L; Fronczek FR; Franzblau SG; Quijano L; Fischer NH
    Planta Med; 1999 May; 65(4):351-5. PubMed ID: 10364842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimycobacterial activities of novel levofloxacin analogues.
    Kawakami K; Namba K; Tanaka M; Matsuhashi N; Sato K; Takemura M
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2126-9. PubMed ID: 10898685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of substitution on the antimycobacterial activity of 2-(substituted benzyl)sulfanyl benzimidazoles, benzoxazoles, and benzothiazoles--a quantitative structure-activity relationship study.
    Pytela O; Klimešová V
    Chem Pharm Bull (Tokyo); 2011; 59(2):179-84. PubMed ID: 21297296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampin against M. tuberculosis in cultured human macrophages.
    Crowle AJ; Elkins N; May MH
    Am Rev Respir Dis; 1988 May; 137(5):1141-6. PubMed ID: 3143278
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and antimycobacterial activity of some 4-pyridinecarboxyamidrazone derivatives.
    Mamolo MG; Vio L; Banfi E; Predominato M; Fabris C; Asaro F
    Farmaco; 1993 Apr; 48(4):529-38. PubMed ID: 8357468
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Promising new drugs in the treatment of tuberculosis and mycobacteriosis.
    Casal M; Rodríguez F; Gutierrez J; Ruiz P; Benavente MC; Villalba R; Moreno G
    J Chemother; 1989 Feb; 1(1):39-45. PubMed ID: 2498468
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sesquiterpene lactones with potential use as natural herbicide models (I): trans,trans-germacranolides.
    Macías FA; Galindo JC; Castellano D; Velasco RF
    J Agric Food Chem; 1999 Oct; 47(10):4407-14. PubMed ID: 10552826
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nifurtimox Is Ineffective against Drug-Resistant Mycobacteria.
    Ruth MM; Sangen JJN; Wertheim HFL; van Ingen J
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652235
    [No Abstract]   [Full Text] [Related]  

  • 51. 1-Aryl-5-benzylsulfanyltetrazoles, a new group of antimycobacterial compounds against potentially pathogenic strains.
    Waisser K; Adamec J; Dolezal R; Kaustová J
    Folia Microbiol (Praha); 2005; 50(3):195-7. PubMed ID: 16295656
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative in-vitro activity of five fluoroquinolones against mycobacteria.
    Davies S; Sparham PD; Spencer RC
    J Antimicrob Chemother; 1987 May; 19(5):605-9. PubMed ID: 3112094
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimycobacterial activity of ferutinin alone and in combination with antitubercular drugs against a rapidly growing surrogate of Mycobacterium tuberculosis.
    Abourashed EA; Galal AM; Shibl AM
    Nat Prod Res; 2011 Jul; 25(12):1142-9. PubMed ID: 21442547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antimycobacterial polyynes of Devil's Club (Oplopanax horridus), a North American native medicinal plant.
    Kobaisy M; Abramowski Z; Lermer L; Saxena G; Hancock RE; Towers GH; Doxsee D; Stokes RW
    J Nat Prod; 1997 Nov; 60(11):1210-3. PubMed ID: 9392889
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antimycobacterial activity of new quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives.
    Ortega MA; Montoya ME; Jaso A; Zarranz B; Tirapu I; Aldana I; Monge A
    Pharmazie; 2001 Mar; 56(3):205-7. PubMed ID: 11265583
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [In-vitro activity of two hybrid synthetic peptides having antimicrobial activity against mycobacteria].
    Zerbini E; Andreu D; Tonarelli G; Sequeira MD
    Rev Argent Microbiol; 2006; 38(4):221-3. PubMed ID: 17370578
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The oriented development of antituberculotics: salicylanilides.
    Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Kaustová J; Möllmann U; Dahse HM; Miko M
    Arch Pharm (Weinheim); 2006 Nov; 339(11):616-20. PubMed ID: 17048291
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel semisynthetic antibiotics from caprazamycins A-G: caprazene derivatives and their antibacterial activity.
    Takahashi Y; Igarashi M; Miyake T; Soutome H; Ishikawa K; Komatsuki Y; Koyama Y; Nakagawa N; Hattori S; Inoue K; Doi N; Akamatsu Y
    J Antibiot (Tokyo); 2013 Mar; 66(3):171-8. PubMed ID: 23532021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative in vitro and in vivo antimicrobial activities of sitafloxacin, gatifloxacin and moxifloxacin against Mycobacterium avium.
    Sano C; Tatano Y; Shimizu T; Yamabe S; Sato K; Tomioka H
    Int J Antimicrob Agents; 2011 Apr; 37(4):296-301. PubMed ID: 21353489
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [New active drugs against the tuberculosis bacillus and other mycobacteria].
    de Kantor IN
    Medicina (B Aires); 1986; 46(1):107-12. PubMed ID: 3100907
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.